Inventor · disambiguated record
William Mitchell
Also filed as: DOUGHTY LEGAL REPRESENTATIVE J · MITCHELL WILLIAM · MITCHELL WILLIAM L · MITCHELL WILLIAM LEONARD
25 granted patents·12 pending applications·338 citations·filing 1987–2018
96Inventor score
Files withGLAXO GROUP LTD17CHDI FOUNDATION INC7EATHERTON ANDREW JOHN5EATHERTON ANDREW J34C DESIGN LTD1
Top patents by PatentIndex Score
37 records- 0195US4997986APhenethanolamine derivativesGLAXO GROUP LTD·Filed 1988·Granted Mar 5, 1991·36 cites·4 claims
- 0293US5283262APhenethanolamine derivativesGLAXO GROUP LTD·Filed 1991·Granted Feb 1, 1994·37 cites·3 claims
- 0393US5109023APhenethanolamine derivativesGLAXO GROUP LTD·Filed 1990·Granted Apr 28, 1992·34 cites·4 claims
- 0493US5099068APhenethanolamine derivativesGLAXO GROUP LTD·Filed 1990·Granted Mar 24, 1992·34 cites·8 claims
- 0592US5045545A[(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activityGLAXO GROUP LTD·Filed 1989·Granted Sep 3, 1991·33 cites·7 claims
- 0687US9428464B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCOURTNEY STEPHEN MARTIN·Filed 2012·Granted Aug 30, 2016·14 cites·3 claims
- 0783US9260422B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2012·Granted Feb 16, 2016·7 cites·10 claims
- 0883US5066678APhenethandamine derivatives and pharmaceutical use thereofGLAXO GROUP LTD·Filed 1990·Granted Nov 19, 1991·23 cites·28 claims
- 0983US4859662ATetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbancesGLAXO GROUP LTD·Filed 1988·Granted Aug 22, 1989·18 cites·21 claims
- 1079US4937268AChemical compoundsGLAXO GROUP LTD·Filed 1988·Granted Jun 26, 1990·26 cites·10 claims
- 1179US4822881ATetrahydro carbazolone intermediatesGLAXO GROUP LTD·Filed 1987·Granted Apr 18, 1989·14 cites·2 claims
- 1278US9884853B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Feb 6, 2018·3 cites·16 claims
- 1377US9822058B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2013·Granted Nov 21, 2017·3 cites·24 claims
- 1476US9938252B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2014·Granted Apr 10, 2018·2 cites·2 claims
- 1574US10442782B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 15, 2019·1 cites·21 claims
- 1671US9649310B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2016·Granted May 16, 2017·1 cites·12 claims
- 1768US9981918B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofTOLEDO SHERMAN LETICIA M·Filed 2012·Granted May 29, 2018·2 cites·3 claims
- 1866US5861414APiperidineacetic acid derivatives useful as fibrinogen antagonist agentGLAXO GROUP LTD·Filed 1995·Granted Jan 19, 1999·23 cites·11 claims
- 1965US7589206B2Pyrrolopyridine derivativesGLAXO GROUP LTD·Filed 2005·Granted Sep 15, 2009·1 cites·13 claims
- 2063US5510350ABenzanilide derivativesGLAXO GROUP LTD·Filed 1994·Granted Apr 23, 1996·14 cites·4 claims
- 2160US7635701B2Pyrimidine derivatives and their use as CB2 modulatorsGLAXO GROUP LTD·Filed 2003·Granted Dec 22, 2009·1 cites·19 claims
- 2255US10501433B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2018·Granted Dec 10, 2019·0 cites·4 claims
- 2354US4939144ATricyclic ketone derivatives as 5-HT antagonistsGLAXO GROUP LTD·Filed 1988·Granted Jul 3, 1990·6 cites·10 claims
- 2454US2010041654A1Pyrimidine Derivatives And Their Use As CB2 ModulatorsEATHERTON ANDREW JOHN·Filed 2009·Application pending·0 cites
- 2551US10428054B2Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofCHDI FOUNDATION INC·Filed 2017·Granted Oct 1, 2019·0 cites·17 claims
- 2651US4950681AKetone derivativesGLAXO GROUP LTD·Filed 1988·Granted Aug 21, 1990·5 cites·10 claims
- 2744US2009018128A1CompoundsEATHERTON ANDREW JOHN·Filed 2007·Application pending·0 cites
- 2843US2008221097A1Imidazopyridine Derivatives as Cannabinoid Receptor LigandsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2941US2008261977A1Pyrimidine Derivatives as Cannabinoid Receptor ModulatorsEATHERTON ANDREW JOHN·Filed 2005·Application pending·0 cites
- 3041US2008280868A1Pyridine Derivatives and Their Use as Cb2 Receptor ModulatorsEATHERTON ANDREW JOHN·Filed 2005·Application pending·0 cites
- 3139US2009264452A12-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory DisordersEATHERTON ANDREW JOHN·Filed 2005·Application pending·0 cites
- 3238US2008280952A1Pyridine Derivatives as Connabinoid Receptor ModulatorsGIBLIN GERARD MARTIN PAUL·Filed 2005·Application pending·0 cites
- 3338US2006247261A1Pyrimidine compoundsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 3436US2017319316A1Ligatures and use thereof4C DESIGN LTD·Filed 2015·Application pending·0 cites
- 3536US2007129367A1Pyridine derivatives as cb2 receptor modulatorsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 3636US2006240048A1Pyridine derivatives as cb2 receptor modulatorsEATHERTON ANDREW J·Filed 2003·Application pending·0 cites
- 3734US2008132505A1Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In MedicineGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →